Research letter
Omalizumab in severe asthma: Evaluation of the clinical impact after its withdrawal
M. D. de Sousaa,, , C. Ferreirab, A. Arrobasb
a Centro Hospitalar Tondela Viseu, Viseu, Portugal
b Centro Hospitalar e Universit??rio de Coimbra, Coimbra, Portugal


  • Impact Factor: 1.560(2016)
  • 5-years Impact Factor: 1,100
  • SCImago Journal Rank (SJR):0,29
  • Source Normalized Impact per Paper (SNIP):0,685